~~<i id='365E2AD1DF'><strike id='365E2AD1DF'><tt id='365E2AD1DF'><pre id='365E2AD1DF'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

entertainment

author：focus 2025-10-02 17:27:40 - browse：928

Monica Bertagnolli -- health policy coverage from STAT — NIH Director Monica Bertagnolli Kevin Dietsch/Getty Images

WASHINGTON — President Biden has promised to require fair prices from drugmakers that use federally funded research — and now, in a major recent move, said he’ll trigger government “march-in” on patents for drugs that run afoul of that goal.

“It’s a simple principle. You shouldn’t pay the highest price in the world for drugs that your tax dollars have already helped create,” Biden said last month as he touted the move at the National Institutes of Health.

But the new NIH director, locked in the center of this debate, isn’t taking any big steps yet.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： BD to buy Edwards patient monitoring unit for $4.2 billion

leisure time

explore

knowledge

Wikipedia

leisure time

AdobeCarbondioxidemonitorshavebeenaroundfordecades.Butin2020,theybecame,almostovernight,ahotcommodit

WSS

Stopping antidepressants leads to symptoms for 1 in 6 patients

IVF doctors demand details after CooperSurgical lawsuit

'Little Tech' descents on D.C., wanting a say in how AI is regulated

State of the Union pitch: Bigger Medicare drug price negotiations

Streamlined flu vaccines recommended by FDA advisory panel

UnitedHealth CEO's Medicaid comments send insurer stocks diving

hotspot

entertainment

leisure time

What does generative AI mean for health care? We asked experts

IVF doctors demand details after CooperSurgical lawsuit

Affirmative action in medical school literally saved lives

Ancient Greek ideas underpin modern concepts of pregnancy

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Change Healthcare: What is it, why does its cyberattack matter?

Medicare details structure of new drug price negotiation program

For pregnant people, addiction treatment shouldn't mean a call to child protective services

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

FDA approves Moderna’s RSV vaccine, its second licensed product

explore

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

Stem cell biologist probes earliest stages of human development

Harvard's David Sinclair gets blowback over aging

State of the Union pitch: Bigger Medicare drug price negotiations

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

explore

knowledge

Wikipedia

leisure time